FDA grants accelerated approval for te... - Lung Cancer Support

Lung Cancer Support

4,003 members2,170 posts

FDA grants accelerated approval for tepotinib for metastatic non-small cell lung cancer with MET exon 14 skipping alterations

Miranda_GO2 profile image
Miranda_GO2Partner
0 Replies

Read more about the FDA approval here: fda.gov/drugs/drug-approval...

This is the second drug approved for MET exon 14 skipping alterations. If you have any questions about this treatment or others, feel free to email us at support@go2foundation.org

Written by
Miranda_GO2 profile image
Miranda_GO2
Partner
To view profiles and participate in discussions please or .

You may also like...

Opdivo and Yervoy combination approved for Non-small cell lung cancer

advanced non-small cell lung cancer (NSCLC) with a PD-L1 level equal to or greater than 1% for...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

the full FDA press release:...

Devastated! my Non-Small Cell Lung Cancer Transformed into Small Cell Lung Cancer

July confirmed that my Non-Small Cell has transformed to Small Cell Lung Cancer. Just completed my...

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

gov/drugs/resources-information-approved-drugs/fda-approves-atezolizumab-first-line-treatment-metast

Cuban vaccination to cure lung cancer

notice on the new Cuban fantastic vaccination for lung cancer It is hailed in USA and Americans...